These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10526141)

  • 21. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum.
    De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U
    J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
    Ng NK; Lee HS; Wong PT
    J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
    Willins DL; Meltzer HY
    Brain Res; 1998 Jan; 781(1-2):291-9. PubMed ID: 9507167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.
    Benloucif S; Galloway MP
    Eur J Pharmacol; 1991 Jul; 200(1):1-8. PubMed ID: 1769366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ipsapirone suppresses food intake in food-deprived rats by an action at 5-HT(1A) receptors.
    Arkle M; Ebenezer IS
    Eur J Pharmacol; 2000 Nov; 408(3):273-6. PubMed ID: 11090644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
    Ichikawa J; Meltzer HY
    Brain Res; 1995 Nov; 698(1-2):204-8. PubMed ID: 8581482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat.
    Bowers BJ; Henry MB; Thielen RJ; McBride WJ
    J Neurochem; 2000 Oct; 75(4):1625-33. PubMed ID: 10987844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex.
    Kuroki T; Dai J; Meltzer HY; Ichikawa J
    Brain Res; 2000 Jul; 872(1-2):204-7. PubMed ID: 10924694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway.
    Boulenguez P; Rawlins JN; Chauveau J; Joseph MH; Mitchell SN; Gray JA
    Neuropharmacology; 1996; 35(11):1521-9. PubMed ID: 9025099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?
    Broqua P; Laude D; Bluet-Pajot MT; Schmidt B; Baudrie V; Chaouloff F
    Neuroendocrinology; 1993 Apr; 57(4):640-7. PubMed ID: 7690117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Brain Res; 2000 May; 865(1):85-90. PubMed ID: 10814735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.
    Volonté M; Ceci A; Borsini F
    J Pharmacol Exp Ther; 1995 Oct; 275(1):358-67. PubMed ID: 7562571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.